you are here: Home News Nppa

Nppa

Relief for pharma sector as govt waives mandatory re-labelling of medicines after GST rate cut
NPPA slashes prices of 37 essential drugs, including paracetamol, atorvastatin, amoxycillin
Essential medicines to be slightly costlier from April 1
Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations
Moneycontrol Selects National Edition: Top stories this morning
Drug pricing watchdog fixes retail rates for 19 formulations, including cancer pills
National drug pricing body fixes ceiling prices of 51 drugs and 2 formulations
Will rise in price caps of essential drugs expose chinks in price control policy?
Commonly used medicines to get 12% more expensive from April
Small retailers, wholesalers are up in arms against pricing, discounts of online pharmacies: Here's why
Centre defends pharma marketing practice code in SC, claims adequacy
Mansukh Mandaviya asks pharma industry to tackle spurious drug menace
In Depth | Spadework begins for affordable medicines in India
Retail prices of common medicines set to rise by a steep 11%
Kamlesh Kumar Pant appointed new NPPA chairman
50% costlier now: NPPA approves price rise for Carbamazepine, Ranitidine, Ibuprofen
NPPA asks drug firms to cut prices in wake of GST rate reduction
COVID-19 update | Health Ministry allocates Remdesivir supply to 19 states, UTs; production to be ramped up
Prices of N-95 masks down by up to 47% after NPPA advisory
Exclusive | COVID-19: NPPA seeks urgent supply details on gloves, PPEs, kits, and ventilators as hoarding fears rise
COVID-19: NPPA asks manufacturers to provide details about stock availability of key HIV, malaria drugs
Coronavirus pandemic | NPPA asks state regulators to ensure masks, sanitisers not sold above MRP
Drug price increase: Who gains big, what it means for the industry
Govt initiates new process to identify essential medicines
Government may list 'essential medical devices', cap trade margin in 30-50% range

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Nppa

Relief for pharma sector as govt waives mandatory re-labelling of medicines after GST rate cut

NPPA slashes prices of 37 essential drugs, including paracetamol, atorvastatin, amoxycillin

Essential medicines to be slightly costlier from April 1

Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations

Moneycontrol Selects National Edition: Top stories this morning

Drug pricing watchdog fixes retail rates for 19 formulations, including cancer pills

National drug pricing body fixes ceiling prices of 51 drugs and 2 formulations

Will rise in price caps of essential drugs expose chinks in price control policy?

Commonly used medicines to get 12% more expensive from April

Small retailers, wholesalers are up in arms against pricing, discounts of online pharmacies: Here's why

Centre defends pharma marketing practice code in SC, claims adequacy

Mansukh Mandaviya asks pharma industry to tackle spurious drug menace

In Depth | Spadework begins for affordable medicines in India

Retail prices of common medicines set to rise by a steep 11%

Kamlesh Kumar Pant appointed new NPPA chairman

50% costlier now: NPPA approves price rise for Carbamazepine, Ranitidine, Ibuprofen

NPPA asks drug firms to cut prices in wake of GST rate reduction

COVID-19 update | Health Ministry allocates Remdesivir supply to 19 states, UTs; production to be ramped up

Prices of N-95 masks down by up to 47% after NPPA advisory

Exclusive | COVID-19: NPPA seeks urgent supply details on gloves, PPEs, kits, and ventilators as hoarding fears rise

COVID-19: NPPA asks manufacturers to provide details about stock availability of key HIV, malaria drugs

Coronavirus pandemic | NPPA asks state regulators to ensure masks, sanitisers not sold above MRP

Drug price increase: Who gains big, what it means for the industry

Govt initiates new process to identify essential medicines

Government may list 'essential medical devices', cap trade margin in 30-50% range